Laboratory of Human Genetics, Medical School and Pharmacy, University Mohammed V, Rabat, Morocco.
Department of Neurology and Neurogenetics, Specialties Hospital, CHU Ibn Sina, Rabat, Morocco.
Pan Afr Med J. 2024 Apr 3;47:159. doi: 10.11604/pamj.2024.47.159.36397. eCollection 2024.
Dopa-responsive dystonia (DRD) is a hereditary movement disorder due to a selective nigrostriatal dopamine deficiency. It is characterized by onset in childhood or adolescence with marked diurnal fluctuation with or without Parkinsonian features, and is caused by mutations in GCH1 gene. We report in this study the clinical and genetic features of the first DRD Moroccan patient. Using a gene panel sequencing, we identified a heterozygous nonsense variant p. Glu61Ter in GCH1. A subsequent targeted segregation analysis by Sanger sequencing validated the presence of the mutation in the patient, which was found to have occurred de novo. The objective of this study is to report the first description of DRD in Morocco, and highlights the importance of new generation sequencing technology in the reduction of medical wandering and the management of hereditary diseases.
多巴反应性肌张力障碍(DRD)是一种遗传性运动障碍,由选择性黑质纹状体多巴胺缺乏引起。其特征是在儿童或青少年期发病,具有明显的昼夜波动,伴有或不伴有帕金森病特征,由 GCH1 基因突变引起。本研究报告了首例摩洛哥 DRD 患者的临床和遗传特征。通过基因 panel 测序,我们在 GCH1 中发现了一个杂合的无义变异 p. Glu61Ter。随后通过 Sanger 测序进行的靶向分离分析证实了该突变存在于患者中,且为新生突变。本研究的目的是报告摩洛哥首例 DRD 的描述,并强调新一代测序技术在减少医疗漫游和遗传性疾病管理方面的重要性。